QT
NKTR icon

Quantbot Technologies’s Nektar Therapeutics NKTR Stock Holding History

Quantbot Technologies’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30K Buy
+417
New +$23.7K ﹤0.01% 1466
2025
Q4 		– Sell
-88
Closed -$5.01K – 2025
2025
Q3 		$5.01K Buy
+88
New +$2.91K ﹤0.01% 1648
2023
Q3 		– Sell
-1,397
Closed -$12.1K – 1820
2023
Q2 		$12.1K Buy
+1,397
New +$14.9K ﹤0.01% 1453
2022
Q4 		– Sell
-3,173
Closed -$152K – 1967
2022
Q3 		$152K Buy
3,173
+2,979
+1,536% +$177K 0.01% 971
2022
Q2 		$11K Buy
194
+181
+1,392% +$11.4K ﹤0.01% 1519
2022
Q1 		$1K Buy
+13
New +$1.92K ﹤0.01% 1585
2021
Q4 		– Sell
-53
Closed -$14K – 1766
2021
Q3 		$14K Buy
+53
New +$12.7K ﹤0.01% 1314
2020
Q3 		– Sell
-102
Closed -$35K – 1523
2020
Q2 		$35K Buy
+102
New +$31.8K ﹤0.01% 774
2020
Q1 		– Sell
-624
Closed -$202K – 1223
2019
Q4 		$202K Buy
+624
New +$181K 0.02% 655
2018
Q3 		– Sell
-1,188
Closed -$869K – 1453
2018
Q2 		$869K Buy
+1,188
New +$1.37M 0.06% 429
2016
Q4 		– Sell
-1,059
Closed -$272K – 1253
2016
Q3 		$272K Buy
+1,059
New +$273K 0.03% 484
2014
Q4 		– Sell
-4,030
Closed -$729K – 1317
2014
Q3 		$729K Buy
4,030
+1,321
+49% +$253K 0.1% 305
2014
Q2 		$520K Buy
+2,709
New +$479K 0.08% 346
2014
Q1 		– Sell
-7
Closed -$1K – 1260
2013
Q4 		$1K Sell
7
-300
-98% -$48.4K ﹤0.01% 951
2013
Q3 		$48K Buy
+307
New +$56.8K 0.03% 525

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Quantbot Technologies's NKTR Position: Q1 2026 in Review

Quantbot Technologies opened a new position in Nektar Therapeutics (NKTR) in Q1 2026: 417 shares worth $30K. The stake represents ﹤0.01% of the portfolio and ranks #1466 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in NKTR as recently as Q3 2025.

Quantbot Technologies first reported a position in NKTR in Q3 2013 and has held it in 15 quarters since. The position peaked at $869K in Q2 2018. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Quantbot Technologies held 417 shares of Nektar Therapeutics worth $30K as of Q1 2026.
  • Nektar Therapeutics was a new Quantbot Technologies position in Q1 2026.
  • Nektar Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q1 2026, its #1466 holding.
  • Quantbot Technologies first reported a position in Nektar Therapeutics in Q3 2013 and has held it in 15 quarters since.
  • Quantbot Technologies's Nektar Therapeutics position peaked at $869K in Q2 2018.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.